Keywords: Sanofi, M&A, Genfar, Eliglustat, Diabetes, Lyxumia, Gaucher's, Bristol-Myers, Plavix, Avapro

Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS

Article | 03 October 2012

Print This

In what turns out to be a very busy couple of days for French drug major Sanofi (Euronext: SAN), the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in